Comprehensive Single Domain Antibody Library Construction & Screening Solution

SdAb Library Construction SdAb Library Screenin Advantage Related Services FAQ Online Inquiry

At Creative Biolabs, we stand at the forefront of antibody engineering, leveraging over two decades of pioneering expertise to unlock the revolutionary potential of Single Domain Antibodies (SdAbs). Our end-to-end platform for Single Domain Antibody (SdAb) Library Construction and Screening is engineered to provide you with unparalleled access to high-affinity, target-specific SdAbs with superior developability characteristics. We integrate state-of-the-art molecular biology, advanced display technologies, and next-generation sequencing (NGS) to build and interrogate vast, diverse SdAb libraries, ensuring the highest probability of identifying lead candidates against your most challenging targets.

Discuss Your Project Today

SdAb Library Construction: Building Your Foundation for Discovery

A high-quality library is the cornerstone of any successful antibody discovery campaign. We offer the construction of three distinct types of SdAb libraries, each with strategic advantages. Our platform leverages advanced cloning techniques and is rigorously monitored by next-generation sequencing (NGS) to guarantee maximum diversity and coverage.

Immune Camelid V_HH Libraries

This is the gold standard for generating high-affinity antibodies against a specific target. By immunizing camelids (Llama, Alpaca, or Camel) with your antigen, we trigger in vivo affinity maturation, naturally selecting for V_HH domains with superior binding characteristics and low immunogenicity.

Our Process:

Antigen Preparation & Immunization Strategy: Expert design of immunization protocols to maximize the desired immune response.
Camelid Immunization: Housing and immunization of animals (Llamas, Alpacas) in our state-of-the-art facilities.
Peripheral Blood Mononuclear Cell (PBMC) Isolation: Extraction of antibody-producing cells at peak immune response.
V_HH Gene Repertoire Cloning: RT-PCR amplification of the V_HH encoding sequences.
Phage/Yeast Display Library Construction: Cloning of the V_HH repertoire into our optimized phagemid or yeast display vectors, routinely achieving library sizes of 10⁸ - 10⁹.
NGS-Powered Quality Control: Deep sequencing analysis to confirm library diversity, assess V_HH family distribution, and verify CDR3 integrity.

Fig. 1 VHH generation from camelid. (OA Literature). Fig. 1 Overview of V_HH generation from camelid.¹

Naïve SdAb Libraries

Constructed from non-immunized healthy camelids, our naïve V_HH libraries represent a vast, natural repertoire of V_HH domains. This "off-the-shelf" resource is ideal for rapid screening campaigns, particularly against toxic or non-immunogenic targets, without the time required for animal immunization.

Key Advantage: Rapid access to a diverse pool of binders for virtually any target.
Library Size: Our premier naïve libraries boast diversity exceeding 10¹⁰.

Synthetic & Semi-Synthetic SdAb Libraries

For ultimate control and rationally designed diversity, our synthetic libraries are unparalleled. Using sophisticated computational algorithms and AI-driven design, we construct V_HH frameworks with tailored diversity incorporated into the complementarity-determining regions (CDRs). This approach allows for the creation of novel specificities not present in nature and frameworks optimized for developability from the outset.

Key Advantage: Precisely controlled diversity, optimized frameworks, and the ability to target novel epitope space. Ideal for "difficult" targets and fine-tuning biophysical properties.
Technology: We utilize trinucleotide-based synthesis and advanced randomization strategies to eliminate stop codons and minimize amino acid bias.

Advanced SdAb Library Screening: Identifying the Perfect Candidate

Creative Biolabs employs cutting-edge display and screening technologies to isolate high-value SdAb candidates from our vast libraries. Our goal is to move beyond simple binding and identify clones with functional activity and favorable characteristics.

Phage Display Screening

Our proprietary phage display platform is a robust and proven method for isolating high-affinity binders. We have optimized our biopanning strategies to meet diverse project needs.

Our Phage Display Biopanning Strategies Include:

Solid-Phase Screening: Immobilizing the target antigen on a solid surface.
Solution-Sorting Screening: Capturing antigen-binder complexes in solution for higher stringency.
Cell-Based Screening: Using whole cells to pan for antibodies against native membrane proteins.
Competitive & Subtractive Panning: Isolating binders with high specificity or those that target a particular epitope.

Yeast Display Screening

Yeast display screening offers significant advantages for screening, particularly for quantitative analysis and fine-tuning. Because the V_HH is displayed on the surface of a eukaryotic cell, it is subject to eukaryotic quality control and allows for:

Quantitative Screening: Use of fluorescence-activated cell sorting (FACS) to directly isolate clones based on affinity and expression level.
Affinity Maturation: An ideal platform for building secondary libraries and performing directed evolution to improve binder affinity from the micromolar to the picomolar range.
Simultaneous Screening for Biophysical Properties: Screen for both high affinity and high stability in a single step.

Deep Screening with Next-Generation Sequencing (NGS)

NGS has revolutionized library screening. We integrate NGS analysis throughout the panning process to provide unprecedented insight into binder enrichment. This data-driven approach allows us to:

Monitor Enrichment Dynamics: Track the convergence of specific V_HH families over each panning round.
Identify Low-Frequency Binders: Rescue promising candidates that may be missed by traditional colony picking.
Provide Comprehensive Datasets: Deliver a complete sequence and frequency analysis of enriched clones, giving you a broad selection of candidates to choose from.

Why Choose Creative Biolabs for Your SdAb Project?

World-Class Expertise: Over two decades of dedicated experience in antibody engineering and discovery.
Technology Leadership: A multi-platform approach utilizing Phage Display, Yeast Display, and integrated NGS analysis for superior results.
Unmatched Library Quality: Guaranteed high-diversity libraries (10⁸-10¹⁰) with rigorous QC at every step.
Customized Strategies: We don't believe in one-size-fits-all. Our PhD-level scientists consult with you to design a project strategy tailored to your specific target and goals.
End-to-End Solution: From antigen design and library construction to hit characterization, affinity maturation, and large-scale production, we are your partner for the entire discovery pipeline.
Proven Track Record: A long history of success, evidenced by numerous peer-reviewed publications and satisfied clients in academia and industry.

Related Featured SdAb Discovery Services

Explore our specialized services to advance your research:

Let our expertise accelerate your research and development. Partner with Creative Biolabs to build a superior single domain antibody library and screen for candidates with game-changing potential.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQ)

Q: How do I choose between an immune, naïve, or synthetic SdAb library for my project?

A: This is an excellent and critical question. The choice depends entirely on your project's specific goals, timeline, and the nature of your target antigen.

Choose an Immune Library if: Your primary goal is to obtain the highest possible affinity binders. The in vivo affinity maturation process within an immunized camelid is nature's own optimization engine and is unparalleled for generating potent, mature antibodies. This is the recommended path for most therapeutic applications, provided your antigen is available and not overly toxic.
Choose a Naïve Library if: Speed is essential, or your target is toxic, non-immunogenic, or highly conserved (making it difficult to elicit an immune response). Our pre-built, high-diversity naïve libraries can be screened immediately, providing a rapid path to a diverse set of binders without any animal work.
Choose a Synthetic Library if: You require ultimate control and rationally designed diversity. This approach is ideal for targeting challenging epitopes (like enzyme active sites), optimizing framework developability from the start, or generating binders against targets that are impossible to use for immunization. Our AI-driven designs can create novel specificities not found in natural repertoires.

Our scientific team will consult with you to analyze your needs and recommend the most strategic and cost-effective library type for your project's success.

Q: What is the typical timeline for a complete SdAb library construction and screening project?

A: The project timeline varies depending on the type of library constructed.

Immune Library Projects: These are the longest, typically taking 14-18 weeks. This includes ~8-10 weeks for camelid immunization and immune response monitoring, followed by 6-8 weeks for library construction, screening (panning), and initial hit validation.
Naïve or Synthetic Library Projects: These are significantly faster, as they skip the immunization step. A typical screening project using one of our existing premier naïve or synthetic libraries can be completed in as little as 6-8 weeks from project initiation to the delivery of enriched binder sequences.

We provide a detailed project timeline with clear milestones at the start of every project.

Q: My target is a difficult membrane protein (e.g., a GPCR or ion channel). Can you still find binders?

A: Absolutely. This is a core area of our expertise. Single domain antibodies are uniquely suited for difficult membrane protein targets due to their small size and convex paratope, which allows them to access cryptic epitopes often hidden from larger conventional antibodies.

Our strategy for such targets includes:

Antigen Strategy: We can work with various antigen formats, including whole cells overexpressing the target, virus-like particles (VLPs), nanodiscs, or purified proteins stabilized in detergents.
Cell-Based Panning: We perform screening directly against native proteins on the cell surface, ensuring that any identified binders recognize the correct conformation.
Advanced Screening Platforms: Our yeast display platform is particularly powerful for these targets, as it allows for precise, quantitative FACS-based sorting to isolate binders with specific functional profiles (e.g., agonists vs. antagonists) directly.

Reference

Wang, Jia, et al. "V_HH antibodies: reagents for mycotoxin detection in food products." Sensors 18.2 (2018): 485. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/s18020485

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.